Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018227179) SMALL-MOLECULE LACTAMS IN COAMORPHOUS PHARMACEUTICAL PHASES
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

What is claimed is:

1) An amorphous dispersion comprising

(a) bis(vinylcaprolactam) and

(b) an active pharmaceutical ing

2) The amorphous dispersion of claim 1, wherein said active pharmaceutical ingredient is selected from the group consisting of


benzocaine caffeine carbamazepine carisoprodol

dopamine ethionamide ibuprofen isoniazid


metformin mexiletine tolfenamic acid


valsartan ROY

and

3) The amorphous dispersion of claim 1, wherein the mole ratio of said active pharmaceutical ingredient to said bis vinylcaprolactam ranges from 1 : 1 to 10: 1.